Stefan van Den Akker

Exec. Director R&d Quality & Risk Management (gcp, Gvp, Glp) at Acadia Pharmaceuticals

Stefan van den Akker has a strong background in clinical research and quality management, with extensive experience in leading quality and risk management in research and development settings. Stefan has held various key roles in reputable pharmaceutical companies such as Acadia Pharmaceuticals Inc. and Novartis. Stefan has a Master of Science degree in (Medical) Biology from Radboud University and has also been actively involved in volunteer work as the treasurer and vice-president of Northern Ghana Volunteers.

Links

Org chart

Timeline

  • Exec. Director R&d Quality & Risk Management (gcp, Gvp, Glp)

    March, 2023 - present

  • Sr Director R D Quality Risk Management GCP GLP GVP

    March, 2019

  • Director R D Quality Risk Management GCP

    January, 2017

  • Director Of GCP Quality Control

    September, 2016

View in org chart